Solid Tumors, Adult Clinical Trials

11 recruiting

Solid Tumors, Adult Trials at a Glance

13 actively recruiting trials for solid tumors, adult are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Phase 1 with 11 trials, with the heaviest enrollment activity in Houston, Tampa, and Boston. Lead sponsors running solid tumors, adult studies include Grit Biotechnology, Hutchmed, and Dicerna Pharmaceuticals, Inc., a Novo Nordisk company.

Browse solid tumors, adult trials by phase

Treatments under study

About Solid Tumors, Adult Clinical Trials

Looking for clinical trials for Solid Tumors, Adult? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Solid Tumors, Adult trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Solid Tumors, Adult clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Phase 2

A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement

Other Solid Tumors, AdultFGFR2 Gene Fusion/Rearrangement
Elevar Therapeutics30 enrolled19 locationsNCT07359820
Recruiting
Phase 1Phase 2

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Breast CancerSolid Tumors, Adult
Eli Lilly and Company880 enrolled66 locationsNCT05768139
Recruiting
Phase 1

GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors

Solid Tumors, Adult
Grit Biotechnology31 enrolled5 locationsNCT05430373
Recruiting
Phase 1

HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors

Solid Tumors, Adult
HighField Biopharmaceuticals Corporation84 enrolled2 locationsNCT05861895
Recruiting
Phase 1Phase 2

HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor

Solid Tumors, Adult
Hutchmed186 enrolled11 locationsNCT07396584
Recruiting
Phase 1Phase 2

A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 )

Solid Tumors, Adult
Abbisko Therapeutics Co, Ltd401 enrolled1 locationNCT07417189
Recruiting
Phase 1

Imaging of Solid Tumors Using FAP-2286

Metastatic CancerSolid Tumors, Adult
Thomas Hope191 enrolled1 locationNCT04621435
Recruiting
Phase 1Phase 2

A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors

Solid Tumors, Adult
Hutchmed147 enrolled11 locationsNCT07228247
Recruiting
Phase 1

Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors

Solid Tumors, Adult
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company32 enrolled2 locationsNCT06504368
Recruiting
Phase 1

TIL Injection for the Treatment of Metastatic or Recurrent Solid Tumors

Solid Tumors, Adult
Grit Biotechnology12 enrolled1 locationNCT06088472
Recruiting
Phase 1Phase 2

A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors

CholangiocarcinomaAdvanced Solid TumorsIntrahepatic Cholangiocarcinoma (Icc)+9 more
Cogent Biosciences, Inc.110 enrolled15 locationsNCT06777316
Recruiting
Phase 1

PANK-003 Cell Injection Combined with Standard Adjuvant Chemotherapy After Surgery in Patients with Solid Tumors

Solid Tumors, Adult
Shenzhen Celconta Life Science Co., Ltd.18 enrolled1 locationNCT06897228
Recruiting
Not Applicable

Low-dose Chemotherapy Under Hypoglycaemia for the Treatment of Relapsed Refractory Advanced Solid Tumours

Solid Tumors, Adult
Wuxi People's Hospital300 enrolled1 locationNCT06404528